JISLJALEQSNSEJain Irrigation Systems Limited· Plastic And Plastic ProductsLowNeutral
Announced Mon, 29 Sept · 18:38 IST

Jain Irrigation Systems Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 29, 2025. Further, the company has informed the Exchange regarding voting results.

Board & Shareholder Meetings View source PDF

JISLJALEQS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Jain Irrigation Systems held its 38th AGM on September 29, 2025, and all 7 resolutions were passed with overwhelming majority. Key items included adoption of audited financial statements for FY25 (99.20% in favour), reappointment of Shri Atul B. Jain as Director retiring by rotation (97.37% in favour), reappointment of Statutory Auditors for a second 5-year term (99.18% in favour), ratification of Cost Auditor remuneration (99.99% in favour), and appointment of a Secretarial Auditor (99.99% in favour). Dr. Narendra Jadhav was reappointed as Independent Director for a second 5-year term with 95.89% approval, and most notably, shareholders approved a Special Resolution to raise funds through a Qualified Institutions Placement (QIP) of equity shares and other eligible securities, with 99.91% voting in favour. The company has two share classes: ordinary equity (1 vote per share) and DVR equity (1 vote per 10 shares). Out of 243,618 total shareholders on record date, about 30.5% of outstanding shares were polled.

Likely market impact

The QIP approval is the most material outcome — it gives the company flexibility to raise fresh capital from institutional investors, which could lead to equity dilution for existing shareholders. The clean passage of all resolutions, including director and auditor reappointments, reflects strong shareholder confidence in the current management. Institutional investors showed notable dissent on the reappointment of Atul B. Jain (18.9% against) and Dr. Narendra Jadhav (29.5% against), which investors may want to monitor.